BNNR

BNNR (Bounded Nuclear Norm Regularization) is a computational method for drug repositioning to identify new indications for existing drugs. The method models drug repositioning as a recommendation system problem and employs matrix completion techniques to predict novel drug-disease associations.

Key features of BNNR:

1. Assumes that the underlying latent factors determining drug-disease associations are highly correlated, resulting in a low-rank drug-disease matrix.

2. Tolerates noisy drug-drug and disease-disease similarities by incorporating a regularization term to balance the approximation error and rank properties.

3. Incorporates additional constraints to ensure all predicted matrix entry values are within a specific interval.

4. Operates on an adjacency matrix of a heterogeneous drug-disease network, integrating drug-drug, drug-disease, and disease-disease networks.

5. Capable of dealing with cold start problems naturally.

Topic

Medicinal chemistry;Preclinical and clinical studies;Safety sciences

Detail

  • Operation: -

  • Software interface: Command-line user interface

  • Language: MATLAB

  • License: Not stated

  • Cost: Free of charge

  • Version name: -

  • Credit: National Natural Science Foundation of China.

  • Input: -

  • Output: -

  • Contact: Jianxin Wang jxwang@mail.csu.edu.cn

  • Collection: -

  • Maturity: -

Publications

  • Drug repositioning based on bounded nuclear norm regularization.
  • Yang M, et al. Drug repositioning based on bounded nuclear norm regularization. Drug repositioning based on bounded nuclear norm regularization. 2019; 35:i455-i463. doi: 10.1093/bioinformatics/btz331
  • https://doi.org/10.1093/BIOINFORMATICS/BTZ331
  • PMID: 31510658
  • PMC: PMC6612853

Download and documentation


< Back to DB search